HR-Positive Metastatic Breast Cancer — An Interview with Dr Erika Hamilton on the Potential Role of PROTAC Estrogen Receptor Degraders
Breast Cancer Update
00:00
Novel PROTAC formats and future applications
She describes photoproTACs, antibody‑PROTAC conjugates and modular opportunities for targeted degradation strategies.
Play episode from 27:41
Transcript
